|
DVL3 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.961200E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.546200E-01 |
| Normal-vs-Stage2 |
2.870400E-01 |
| Normal-vs-Stage3 |
9.034200E-01 |
| Normal-vs-Stage4 |
6.759200E-01 |
| Stage1-vs-Stage2 |
3.288400E-01 |
| Stage1-vs-Stage3 |
4.760200E-01 |
| Stage1-vs-Stage4 |
2.966000E-01 |
| Stage2-vs-Stage3 |
2.043400E-01 |
| Stage2-vs-Stage4 |
1.404830E-01 |
| Stage3-vs-Stage4 |
7.330600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.680000E-01 |
| Normal-vs-AfricanAmerican |
2.524800E-01 |
| Normal-vs-Asian |
2.199000E-01 |
| Caucasian-vs-AfricanAmerican |
9.152400E-02 |
| Caucasian-vs-Asian |
1.236570E-01 |
| AfricanAmerican-vs-Asian |
4.443400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.349400E-01 |
| Normal-vs-Female |
1.677960E-01 |
| Male-vs-Female |
1.247080E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.827030E-01 |
| Normal-vs-Age(41-60Yrs) |
6.819800E-01 |
| Normal-vs-Age(61-80Yrs) |
3.077000E-01 |
| Normal-vs-Age(81-100Yrs) |
1.944230E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.032000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.428100E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.101900E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.530500E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.417600E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.617400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.466240E-02 |
| Normal-vs-Grade 2 |
5.953000E-01 |
| Normal-vs-Grade 3 |
4.845400E-01 |
| Normal-vs-Grade 4 |
3.001400E-01 |
| Grade 1-vs-Grade 2 |
3.976400E-02 |
| Grade 1-vs-Grade 3 |
2.040400E-03 |
| Grade 1-vs-Grade 4 |
5.790300E-02 |
| Grade 2-vs-Grade 3 |
7.565600E-01 |
| Grade 2-vs-Grade 4 |
5.300300E-02 |
| Grade 3-vs-Grade 4 |
4.498400E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.138800E-01 |
| Normal-vs-ccB subtype |
4.501000E-01 |
| ccA subtype-vs-ccB subtype |
5.682300E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.999400E-01 |
| Normal-vs-N1 |
1.692450E-01 |
| N0-vs-N1 |
1.586770E-01 |
|
|
